LCM
TEVA icon

Laurion Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Laurion Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-126,900
Closed -$1.24M – 1068
2019
Q4 		$1.24M Buy
+126,900
New +$1.13M 0.01% 532
2019
Q3 		– Sell
-250,000
Closed -$2.31M – 1279
2019
Q2 		$2.31M Buy
+250,000
New +$3.01M 0.02% 361
2019
Q1 		– Sell
-80,000
Closed -$1.23M – 1277
2018
Q4 		$1.23M Hold
80,000
– – 0.02% 508
2018
Q3 		$1.72M Hold
80,000
– – 0.02% 570
2018
Q2 		$1.95M Hold
80,000
– – 0.02% 610
2018
Q1 		$1.37M Sell
80,000
-667,500
-89% -$13M 0.01% 747
2017
Q4 		$14.2M Sell
747,500
-153,000
-17% -$2.3M 0.07% 272
2017
Q3 		$15.8M Buy
900,500
+733,000
+438% +$16.5M 0.07% 219
2017
Q2 		$5.57M Hold
167,500
– – 0.03% 473
2017
Q1 		$5.38M Buy
167,500
+125,000
+294% +$4.27M 0.04% 403
2016
Q4 		$1.54M Sell
42,500
-410,600
-91% -$16.4M 0.01% 637
2016
Q3 		$20.8M Buy
453,100
+373,500
+469% +$19.5M 0.2% 116
2016
Q2 		$4M Sell
79,600
-180,400
-69% -$9.6M 0.06% 303
2016
Q1 		$13.9M Buy
260,000
+100,000
+63% +$5.87M 0.22% 114
2015
Q4 		$10.5M Buy
+160,000
New +$9.89M 0.1% 213
2014
Q3 		– Sell
-200,000
Closed -$10.5M – 391
2014
Q2 		$10.5M Buy
+200,000
New +$10.2M 0.22% 133

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Laurion Capital Management's TEVA Position: Q4 2020 in Review

Laurion Capital Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020, closing a stake of 116,600 shares — an estimated $1.05M sold.

Laurion Capital Management first reported a position in TEVA in Q3 2015 and held it in 16 quarters. The position peaked at $40.8M in Q3 2016. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Laurion Capital Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2020 after selling out during the quarter.
  • Laurion Capital Management sold 116,600 Teva Pharmaceutical Industries Limited shares in Q4 2020, an estimated $1.05M.
  • Laurion Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2015 and held it in 16 quarters.
  • Laurion Capital Management's Teva Pharmaceutical Industries Limited position peaked at $40.8M in Q3 2016.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.